Literature DB >> 21921041

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.

Siok-Bian Ng1, Junli Yan, Gaofeng Huang, Viknesvaran Selvarajan, Jim Liang-Seah Tay, Baohong Lin, Chonglei Bi, Joy Tan, Yok-Lam Kwong, Norio Shimizu, Katsuyuki Aozasa, Wee-Joo Chng.   

Abstract

We performed a comprehensive genome-wide miRNA expression profiling of extranodal nasal-type natural killer/T-cell lymphoma (NKTL) using formalin-fixed paraffin-embedded tissue (n = 30) and NK cell lines (n = 6) compared with normal NK cells, with the objective of understanding the pathogenetic role of miRNA deregulation in NKTL. Compared with normal NK cells, differentially expressed miRNAs in NKTL are predominantly down-regulated. Re-expression of down-regulated miRNAs, such as miR-101, miR-26a, miR26b, miR-28-5, and miR-363, reduced the growth of the NK cell line and modulated the expression of their predicted target genes, suggesting the potential functional role of the deregulated miRNAs in the oncogenesis of NKTL. Taken together, the predicted targets whose expression is inversely correlated with the expression of deregulated miRNA in NKTL are significantly enriched for genes involved in cell cycle-related, p53, and MAPK signaling pathways. We also performed immunohistochemical validation for selected target proteins and found overexpression of MUM1, BLIMP1, and STMN1 in NKTL, and notably, a corresponding increase in MYC expression. Because MYC is known to cause repression of miRNA expression, it is possible that MYC activation in NKTL may contribute to the suppression of the miRNAs regulating MUM1, BLIMP1, and STMN1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921041     DOI: 10.1182/blood-2011-07-364224

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Authors:  Christof Schneider; Manu Setty; Antony B Holmes; Roy L Maute; Christina S Leslie; Lara Mussolin; Angelo Rosolen; Riccardo Dalla-Favera; Katia Basso
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

2.  Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Haobo Huang; Liping Fan; Rong Zhan; Shunquan Wu; Wenyan Niu
Journal:  Oncol Lett       Date:  2015-10-27       Impact factor: 2.967

3.  Management of advanced NK/T-cell lymphoma.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

4.  MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors.

Authors:  M Braoudaki; G I Lambrou; S A Papadodima; K Stefanaki; N Prodromou; E Kanavakis
Journal:  Med Oncol       Date:  2015-12-23       Impact factor: 3.064

Review 5.  Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.

Authors:  Rong-Li Zheng; Yu-Jie Jiang; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

6.  MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.

Authors:  Ruiguang Zhang; Yan Li; Xiaochuan Dong; Li Peng; Xiu Nie
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

7.  JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

Authors:  A Bouchekioua; L Scourzic; O de Wever; Y Zhang; P Cervera; A Aline-Fardin; T Mercher; P Gaulard; R Nyga; D Jeziorowska; L Douay; W Vainchenker; F Louache; C Gespach; E Solary; P Coppo
Journal:  Leukemia       Date:  2013-05-21       Impact factor: 11.528

Review 8.  Transcriptional and post-transcriptional regulation of NK cell development and function.

Authors:  Jeffrey W Leong; Julia A Wagner; Aaron R Ireland; Todd A Fehniger
Journal:  Clin Immunol       Date:  2016-03-03       Impact factor: 3.969

Review 9.  MicroRNA function in NK-cell biology.

Authors:  Aimee M Beaulieu; Natalie A Bezman; Jang Eun Lee; Mehrdad Matloubian; Joseph C Sun; Lewis L Lanier
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

Review 10.  microRNA-mediated regulation of the tumor microenvironment.

Authors:  Jonathan Chou; Payam Shahi; Zena Werb
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.